Investigators showed that promyelocytic leukemia protein (PML) knockdown in MDA-MB-231, but not MCF7, breast cancer cells, prolonged stem-cell-like survival, and increased cell proliferation and migration, which was in line with gene-enrichment results from their RNA sequencing analysis.
[Molecular Oncology]